Mobile-health Network Solutions (MNDR) investor relations material

Executive summary

• FY2026 revenue rose 1.2% YoY to $7.74M; net loss narrowed to $3.19M from $3.38M, while operating cash use fell to $1.53M from $4.36M.

• Telemedicine and other services remained the core business at 91.3% of revenue; private telemedicine transactions fell 14.5% YoY.

• Recurring losses and operating cash outflows prompted a substantial-doubt going-concern warning; planned financing and cost measures have not alleviated that doubt.

Financial highlights

• Revenue $7.74M, up 1.2% YoY; gross profit $1.64M, up 28.3%, as cost of revenue declined 4.2% to $6.10M.

• Net loss $3.19M vs. $3.38M in FY2025; operating expenses were $4.85M, including $1.54M share-based compensation.

• Adjusted EBITDA loss improved to $1.35M from $2.59M; excludes finance costs, taxes, D&A, share-based compensation and IPO-related expenses.

• Salaries and benefits fell 36.9% to $0.99M; SG&A fell 24.3% to $2.02M, while D&A rose 69.9% to $0.29M.

• Cash and equivalents were $2.55M at June 30, 2026, vs. $1.03M a year earlier; total assets were $11.37M vs. $4.45M.

Outlook and guidance

• Management expects available liquidity and cash from sales and services to fund operations and requirements for at least 12 months; additional equity or debt may be needed if profitability is delayed.

• The auditor cited substantial doubt about going concern; management’s ATM, SEPA, private-placement and cost-optimization plans have not alleviated the doubt.

• Planned priorities include AI-enabled operating efficiency, user engagement, broader healthcare offerings, and partnerships or expansion in APAC and Ghana.